The round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial
Read more
According to a study led by the Institut de Neurociències of the UAB, Osanetant decreases the intensity with which the memory of fear is consolidated, thus preventing the onset of post-traumatic stre...
Read more
The automated analysis of this biomarker, phospho-tau217, is more than 90% effective in identifying patients with Alzheimer's disease. It is an easy-to-use tool that can partly replace other, more com...
Read more
The work has led to the development of a new assessment scale called the ‘Girona Score’, which helps identify patients at greater risk of disability during the three months following the acute pha...
Read more
The funding will drive two preclinical development programs for its groundbreaking drug, ACT-02—an innovative compound with potential disease-modifying properties. ACT-02 functions as an inhibitor o...
Read more
Each tumour is unique, and predicting the therapeutic response to non-small cell lung cancer is a breakthrough in personalized medicine. Given this challenge in biomedicine, the study confirms that th...
Read more
Un estudio realizado por los grupos de Neuropsicofarmacología e IBeA de la UPV/EHU allana el camino para conseguir biomarcadores de pronóstico del desarrollo de la enfermedad
Read more
Más de 500 pacientes ya se han beneficiado de la estimulación cerebral profunda que, junto al HIFU y la radiación Gammaknife, constituyen las técnicas más innovadoras en los casos más complejos ...
Read more
Investigadores del Cima Universidad de Navarra sugieren que la inhibición de FKBP51 abre una vía a nuevas estrategias terapéuticas para los pacientes
Read more
This syndrome is the one that has received the financial donation from Cellers Maset, that through the Pau Massana scholarship collaborates annually with the Parc Taulí Research and Innovation Instit...
Read more
A team from the Sant Pau Research Institute (IR Sant Pau), in collaboration with the Catalan Down Syndrome Foundation, has published in the journal Annals of Neurology the largest study to date on bra...
Read more
El estudio, recientemente publicado en Nature Genetics, revela que las mutaciones en un gen no codificante llamado RNU2-2, que hasta ahora había pasado desapercibido, son responsables de trastornos d...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
